Ambiq Micro (NYSE:AMBQ – Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.49) EPS for the quarter, topping analysts’ consensus estimates of ($0.61) by $0.12, Zacks reports. The firm had revenue of $20.74 million during the quarter, compared to analyst estimates of $19.00 million. Ambiq Micro updated its Q1 2026 guidance to -0.390–0.330 EPS.
Here are the key takeaways from Ambiq Micro’s conference call:
- Ambiq closed 2025 with its highest quarterly sales, reporting $20.7M in Q4 and a 45.5% non-GAAP gross margin, with gross profit rising every quarter and a record annual gross profit.
- Management expects “outsized” top-line growth in 2026, sees a clear path to >$100M in revenue driven by ramping of a scaled global customer, broader Apollo5 adoption, and multiple new product launches.
- Product roadmap acceleration: Ambiq unveiled Atomic (TSMC FinFET, operation down to 300 mV with integrated NPU/GPU/embedded memory) and is accelerating development of Apollo340 and Atomic120 to target advanced wearables, AR/eyewear, smart cameras, and industrial/medical edge AI use cases.
- Ambiq is substantially increasing spending in 2026—R&D and SG&A rose in Q4 and the company expects roughly a $30M YoY OpEx increase (including $7M–$10M of IP purchases and variable contract engineering), and warned margins could face pressure from broader industry/fab and supply-chain cost dynamics.
Ambiq Micro Price Performance
Shares of NYSE AMBQ traded down $1.28 during mid-day trading on Friday, hitting $28.78. The company had a trading volume of 258,991 shares, compared to its average volume of 298,920. Ambiq Micro has a 12 month low of $22.12 and a 12 month high of $51.76. The firm has a market cap of $526.96 million and a P/E ratio of -1.46. The business’s 50-day simple moving average is $31.15 and its 200-day simple moving average is $30.98.
Analyst Ratings Changes
Get Our Latest Stock Report on Ambiq Micro
Ambiq Micro News Summary
Here are the key news stories impacting Ambiq Micro this week:
- Positive Sentiment: Q4 results beat expectations — Ambiq reported revenue above consensus and beat EPS estimates, showing sequential net-sales growth and AI-driven margin expansion that supports the company’s edge-AI story. MarketBeat Q4 earnings
- Positive Sentiment: Stronger-than-expected Q1 2026 guidance — management set Q1 EPS guidance (-$0.390 to -$0.330) and revenue guidance ($21–$22M) that are both better than consensus, signaling improvement in operating leverage. BusinessWire press release
- Positive Sentiment: Management is projecting a path to $100M+ revenue in 2026 and accelerating edge-AI product launches — a growth narrative that could materially change revenue scale and margins if execution continues. Seeking Alpha revenue path story
- Neutral Sentiment: Call materials and transcripts are available — the earnings call, slide deck and transcripts were posted for investors to review management detail and product roadmaps (useful for diligence but not an immediate price mover). Earnings call transcript
- Negative Sentiment: Company remains loss-making and guidance still implies negative EPS — Q4 was profitable vs. expectations in a beat context, but Ambiq reported a net loss for the quarter and the forward EPS range is still negative; investors may be discounting valuation and execution risk. Market data also shows the stock is below its 50‑day/200‑day averages proximity and trading on lighter-than-average volume today. MarketBeat stock profile
Insider Buying and Selling at Ambiq Micro
In related news, CTO Scott Mclean Hanson sold 10,000 shares of the firm’s stock in a transaction on Monday, January 26th. The stock was sold at an average price of $31.00, for a total value of $310,000.00. Following the completion of the transaction, the chief technology officer directly owned 122,818 shares of the company’s stock, valued at $3,807,358. This trade represents a 7.53% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Joseph A. Tautges sold 7,800 shares of the business’s stock in a transaction on Monday, January 26th. The shares were sold at an average price of $31.00, for a total transaction of $241,800.00. Following the completion of the sale, the director directly owned 48,746 shares in the company, valued at $1,511,126. This trade represents a 13.79% decrease in their position. The disclosure for this sale is available in the SEC filing.
Institutional Investors Weigh In On Ambiq Micro
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Rhumbline Advisers bought a new stake in shares of Ambiq Micro during the third quarter worth approximately $119,000. JPMorgan Chase & Co. acquired a new stake in Ambiq Micro during the 3rd quarter worth $56,000. Vanguard Group Inc. bought a new stake in shares of Ambiq Micro during the 3rd quarter valued at $9,210,000. Franklin Resources Inc. acquired a new position in shares of Ambiq Micro in the 3rd quarter valued at $358,000. Finally, BNP Paribas Financial Markets acquired a new position in shares of Ambiq Micro in the 3rd quarter valued at $28,000.
Ambiq Micro Company Profile
Ambiq Micro (NYSE: AMBQ) is a semiconductor company specializing in the design and development of ultra-low-power microcontroller units (MCUs) and application-specific integrated circuits (ASICs). The company’s core technology leverages sub-threshold voltage operation to dramatically reduce energy consumption, enabling extended battery life in a broad range of portable and always-on devices. Ambiq’s products are particularly well suited for applications where power efficiency is critical, such as wearable electronics, IoT sensors, medical monitoring equipment, and industrial automation systems.
The company’s flagship product family, the Apollo series of MCUs, offers multi-core architectures, integrated wireless connectivity options, and advanced security features.
Further Reading
- Five stocks we like better than Ambiq Micro
- Is Elon Preparing for a Silver Shock?
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- Your name isn’t on our protected list yet
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Ambiq Micro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambiq Micro and related companies with MarketBeat.com's FREE daily email newsletter.
